Shane Darrell Lea's most recent trade in Cellectar Biosciences Inc was a trade of 260,000 Stock option (right to buy) done . Disclosure was reported to the exchange on June 14, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cellectar Biosciences Inc | Darrell Shane Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 260,000 | 260,000 | - | - | Stock option (right to buy) | |
Cellectar Biosciences Inc | Shane Darrell Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 100,000 | 100,000 | - | - | Stock option (right to buy) | |
Cellectar Biosciences Inc | Shane Darrell Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 39,599 | 39,599 (0%) | 0% | 0 | Common Stock | |
Cellectar Biosciences Inc | Darrell Shane Lea | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2022 | 100,000 | 100,000 | - | - | Stock option (right to buy) |